This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: COF, EA, NYX, MAKO


AAR Corp. (AIR) was downgraded to Hold at TheStreet Ratings.

Aecom Technology (ACM) was downgraded at Bank of America/Merrill Lynch to Underperform. $20 price target. Company lacks near-term catalysts and is a potential value trap, BofA/Merrill said.

Capital One (COF - Get Report) was upgraded at Argus from Sell to Hold. Valuation call.

Cognizant (CTSH) was upgraded from Neutral to Outperform at Robert Baird. Valuation call, based on a $76 price target, Baird said.

Dresser-Rand (DRC) was upgraded at Morgan Stanley from Equal-Weight to Overweight. $65 price target. Lower natural gas prices are boosting demand for downstream activity, Morgan Stanley said.

Electronic Arts (EA - Get Report) was upgraded at Needham from Hold to Buy. $22 price target. Strong sales growth can expand margins, Needham said.

Goldman Sachs (GS) was downgraded to Hold at TheStreet Ratings.

HSN (HSNI) was upgraded at Citigroup to Buy from Neutral. $42.50 price target. Compelling valuation and accelerating buyback, Citi said.

Louisiana-Pacific (LPX) was upgraded at Deutsche Bank from Hold to Buy. $12 price target. Housing demand is beginning to recover, Deutsche said.

Mako Surgical (MAKO) was downgraded at William Blair to Market Perform. Estimates were also cut, given the company's new guidance, William Blair said.

Millennial Media (MM) was initiated with an Equal-weight rating at Morgan Stanley. Valuation call, Morgan Stanley said.

NYSE Euronext (NYX) was upgraded at Stifel Nicolaus from Sell to Hold. Valuation call, Stifel Nicolaus said.

Rexnord (RXN) was initiated with a Neutral rating at Goldman Sachs. Valuation call, based on a $24 price target, Goldman said.

Synchronoss (SNCR) was downgraded at Wells Fargo to Market Perform. Company cut its guidance because of AT&T (T), Wells Fargo said.

Vertex Pharmaceuticals (VRTX - Get Report) was upgraded at Morgan Stanley from Underweight to Equal-Weight. $51 price target. Interim cystic fibrosis data were better than expected, Morgan Stanley said.

Vertex Pharmaceuticals was upgraded at Brean Murray. Cystic Fibrosis treatment is performing better than expected in trials. Brean Murray said.

Exco Resources (XCO) was upgraded at Keybanc from Hold to Buy. $10 price target. Stock has underperformed, but the company is getting aggressive with its cost controls, Keybanc said.

Cimarex Energy (XEC) was upgraded at Canaccord Genuity from Hold to Buy. $84 price target. Stock is attractive, following a 20% decline, Canaccord said.
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
NYX $0.00 0.00%
MAKO $0.00 0.00%
COF $73.37 -1.26%
EA $62.32 -1.63%
VRTX $86.75 2.66%


Chart of I:DJI
DOW 17,830.76 -210.79 -1.17%
S&P 500 2,075.81 -19.34 -0.92%
NASDAQ 4,805.2910 -57.85 -1.19%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs